adenosine monophosphate has been researched along with Osteoarthritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bai, H; Gao, L; Jiao, G; Li, T; Liu, L; Ma, T; Song, X; Wang, X; Zhang, Z | 1 |
Nuti, R; Righi, GA; Turchetti, V; Vattimo, A | 1 |
1 trial(s) available for adenosine monophosphate and Osteoarthritis
Article | Year |
---|---|
[Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium].
Topics: Adenosine Monophosphate; Anabolic Agents; Arthritis, Rheumatoid; Bone and Bones; Calcium; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intestinal Absorption; Minerals; Nandrolone; Nandrolone Decanoate; Osteoarthritis; Random Allocation | 1984 |
1 other study(ies) available for adenosine monophosphate and Osteoarthritis
Article | Year |
---|---|
CF101 alleviates OA progression and inhibits the inflammatory process via the AMP/ATP/AMPK/mTOR axis.
Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Cartilage, Articular; Chondrocytes; Collagen Type II; Disease Models, Animal; Inflammation; Osteoarthritis; Rats; TOR Serine-Threonine Kinases | 2022 |